PLGA包封灭活病毒疫苗经黏膜递送对牙鲆VHSV感染的保护效果
本研究将灭活VHSV疫苗包封于PLGA纳米颗粒(PNPs-IV),对牙鲆先经浸泡初免、两周后分别以浸泡或口服方式加强免疫,攻毒后RPS分别为60%和73.3%,血清、皮肤黏液和肠黏液特异性抗体显著升高,系统与黏膜免疫组织多种免疫基因转录显著上调。
要点
- PNPs-IV浸泡/浸泡组攻毒后RPS为60%,浸泡/口服组为73.3%。
- 免疫组血清、皮肤黏液和肠黏液抗VHSV抗体滴度显著升高(p<0.05)。
- 免疫组肾脏、皮肤和肠道免疫基因转录显著上调(p<0.05)。
核心结论
- PLGA包封灭活VHSV疫苗经浸泡初免加浸泡或口服加强免疫,可有效保护牙鲆抵抗VHSV攻毒。
研究设计与样本
- 研究以12.5±1.5 g牙鲆为对象,将灭活VHSV疫苗包封于PLGA纳米颗粒(PNPs-IV),先经浸泡初免,两周后以同剂量分别经浸泡或口服加强免疫。
- 攻毒剂量为每尾鱼1×10^6 TCID50强毒VHSV分离株,评估累积死亡率和相对存活率(RPS)。
主要发现
- 攻毒后PNPs-IV浸泡/浸泡组RPS为60%,PNPs-IV浸泡/口服组RPS为73.3%,免疫组累积死亡率低于未免疫组。
- 免疫后免疫组血清、皮肤黏液和肠黏液抗VHSV抗体滴度显著升高(p<0.05)。
- 免疫后及攻毒后,免疫组肾脏、皮肤和肠道中IgM、IgT、pIgR、MHC-I、MHC-II、IFN-γ和Caspase3等免疫基因转录显著上调(p<0.05)。
关键数值与推荐
- PNPs-IV浸泡/浸泡组RPS为60%,PNPs-IV浸泡/口服组RPS为73.3%。
- 攻毒剂量为1×10^6 TCID50病毒/尾。
- 免疫后抗体滴度升高和免疫基因转录上调的显著性水平均为p<0.05。
临床怎么用
- 提示PLGA纳米颗粒包封灭活VHSV疫苗可作为牙鲆黏膜递送(浸泡/口服)的候选免疫策略,替代注射途径。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Viral haemorrhagic septicaemia virus (VHSV), an OIE listed viral pathogen, is the etiological agent of a contagious disease, causing huge economic losses in farmed olive flounder (Paralichthys olivaceus) and significant mortalities among several other marine fish species in Korea, Japan, and China. In continuation with our previous work, where injection vaccination with inactivated VHSV mixed with squalene (as adjuvant) conferred higher protective immunity to olive flounder, the present study focused on replacing the injection route of vaccine delivery by immersion/oral route to overcome the limitations of the parenteral immunization method. Here, we encapsulated the inactivated VHSV vaccine with PLGA (poly lactic-co-glycolic acid) nanoparticles (PNPs-IV) and evaluated its ability to induce protective immunity in olive flounder (12.5 ± 1.5 g) by initially immunizing the fishes by immersion route followed by a booster with the same dose two weeks later with half of the fish through immersion route and other half through oral route (incorporated into fish feed). Cumulative mortalities post-challenge (1 × 106 TCID50 virus/fish) with virulent VHSV-isolate, were lower in vaccinated fish and RPS of 60% and 73.3% were obtained for PNPs-IV (immersion/immersion) and PNPs-IV (immersion/oral) groups, respectively. In addition, specific (anti-VHSV) antibody titre in the fish sera, skin mucus and intestinal mucus of the immunized groups were significantly (p < 0.05) enhanced following vaccination. Furthermore, PNPs-IV immunized fish showed significant (p < 0.05) upregulation of different immune gene transcripts (IgM, IgT, pIgR, MHC-I, MHC-II, IFN-γ, and Caspase3) compared to controls, in both the systemic (kidney) and mucosal (skin and intestine) immune compartment of the host post immunization as well as post challenge. Thus it can be inferred that the adopted immunization strategy efficiently protected and transported the inactivated viral antigen to target immune organs and positively stimulated the protective immune response against VHSV in olive flounder.
引用
- Kole S, Qadiri SSN, Shin SM, et al. PLGA encapsulated inactivated-viral vaccine: Formulation and evaluation of its protective efficacy against viral haemorrhagic septicaemia virus (VHSV) infection in olive flounder (Paralichthys olivaceus) vaccinated by mucosal delivery routes. Vaccine. 2019. PMID: 30661835. doi:10.1016/j.vaccine.2018.12.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。